title: Intratracheal sildenafil in the newborn with pulmonary hypertension.
authors.forename: Miguel
authors.initials: M
authors.lastname: Martell
authors.forename: Fernanda
authors.initials: F
authors.lastname: Blasina
authors.forename: Fernando
authors.initials: F
authors.lastname: Silvera
authors.forename: Salvador
authors.initials: S
authors.lastname: Tellechea
authors.forename: Carolina
authors.initials: C
authors.lastname: Godoy
authors.forename: Lucía
authors.initials: L
authors.lastname: Vaamonde
authors.forename: Luana
authors.initials: L
authors.lastname: Benenatti
authors.forename: Walter
authors.initials: W
authors.lastname: Olivera
mesh_terms: D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate